Disclosures for "Correlating Testing for Rare Genetic Variants with a Broad Clinicopathologic Spectrum of Congenital Myopathies")
-
Dr. Jayaraman has nothing to disclose.
-
Ms. Genetti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics .
-
Dr. Aykanat has nothing to disclose.
-
Ms. Win has nothing to disclose.
-
Mr. Valivullah has nothing to disclose.
-
Ms. O'Heir has nothing to disclose.
-
The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
-
Mrs. Laine has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
-
Ms. O'Donnell-Luria has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tome Biosciences. Ms. O'Donnell-Luria has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Congenica Inc. Ms. O'Donnell-Luria has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Simons Foundation SPARK for Autism. The institution of Ms. O'Donnell-Luria has received research support from Mather's Foundation. The institution of Ms. O'Donnell-Luria has received research support from Chan Zuckerberg Initiative.
-
Alan Beggs, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for F. HOFFMANN-LAROCHE, LTD. Alan Beggs, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for A Foundation Building Strength. Alan Beggs, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Inc. Alan Beggs, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. An immediate family member of Alan Beggs, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Alan Beggs, PhD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kate Therapeutics. Alan Beggs, PhD has stock in Kate Therapeutics. The institution of Alan Beggs, PhD has received research support from NIH. The institution of Alan Beggs, PhD has received research support from MDA. Alan Beggs, PhD has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Alan Beggs, PhD has received publishing royalties from a publication relating to health care.